mazer_rackham
Long

GILD putting in a 3 week tight base pattern?

NASDAQ:GILD   GILEAD SCIENCES INC
Technically, this would not qualify for a 3wk tight pattern. IBD sets the buy point at 123.47. However, IBD also has an advanced buying strategy buy point based on the break of the downward trend line of the left side of the base. The last 3 weeks have had tight closes after they have broken this trend line as they are less than 1% apart. Now seems to be a safe time to step in and wait for lift off.

I like the fundamentals of this company the best out of all the big biotech names. It looks like it's calming down here finally after having been sold off hard with all the other biotech / med companies, and now has consolidated and held above the orange downtrend lines. It keeps putting in higher lows on the weekly chart. This looks like a good place to enter here.

Initial entry will be the break of the 3 wk             tight pattern at 111.50
Add at 114.00 as it breaks the double bottom peak .
Add as it breaks to new highs at 123.47 IBD buy point.

It holds a 91 composite rating on IBD, weak A/D rating of D+, everything else looks good on the company.

IBD STOCK CHECKUP®
Enter Stock Symbol/Company
GET STOCK CHECKUP
Gilead Sciences Inc             (GILD)

ABOUT GILD: DEVELOPS THERAPEUTICS TO TREAT VIRAL, FUNGAL, RESPIRATORY AND CARDIOVASCULAR DISEASES.
D+.

Composite Rating 91
MARKET DIRECTION AND INDUSTRY GROUP FOR GILD

General Market
Market in confirmed uptrend
Industry Group
Industry Group Rank (1 to 197) 47
FUNDAMENTAL PERFORMANCE FOR GILD

Current Earnings
EPS             Due Date 02/01/2016
EPS             Rating 97
EPS             % Chg             (Last Qtr) 75%
Last 3 Qtrs Avg EPS             Growth 69%
# Qtrs of EPS             Acceleration 1
EPS             Est % Chg             (Current Qtr) 21%
Estimate Revisions
Last Quarter % Earnings Surprise 12.2%
Annual Earnings
3 Yr EPS             Growth Rate 106%
Consecutive Yrs of Annual EPS             Growth 4
EPS             Est % Chg             for Current Year 51%
Sales, Margin, ROE
SMR Rating A
Sales % Chg             (Last Qtr) 37%
3 Yr Sales Growth Rate 60%
Annual Pre-Tax Margin 65.0%
Annual ROE 99.4%
Debt/Equity Ratio 77%
TECHNICAL PERFORMANCE FOR GILD

Price And Volume
Price $108.40
RS             Rating 71
% Off 52 Week High -12%
Price vs. 50-Day Moving Average 4%
50-Day Average Volume 11.8 Mil
Supply And Demand
Market Capitalization $159.3 B
Accumulation/Distribution Rating D+
Up/Down Volume 1.4
% Change In Funds Owning Stock 2%
Qtrs Of Increasing Fund Ownership 8
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out